Report Overview:
The Global Eubiotics Market achieved a valuation of $4.87 Billion in 2022 and is anticipated to exceed $9.63 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 8.9% during the forecast period from 2024 to 2032.
Key Market Players:
DSM (Netherlands), Novus International Inc. (U.S.), UAS Laboratories (U.S.) Lallemand Inc. (Canada), Calpis Co....
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek